call for inter-African partnerships in the pharmaceutical industry

2023-11-10 14:58:44 ALGIERS – The Secretary General of the Ministry of Industry and Pharmaceutical Production, Drifa Khoudhir, called in Bamako (Mali) to realize inter-African partnerships in the field of the pharmaceutical industry. Representative of the Minister of the sector, Ali Aoun, at the work of the 2nd edition of the International Health Fair “Keneya Expo2023”, … Read more

Sanofi separates from its Consumer Health division and prepares a savings plan

2023-10-27 10:40:19 Sanofi will separate its Consumer Health division (Doliprane, Mucosolvan, etc.) by listing it separately on the stock market in 2024 to focus on new growth drivers in innovative medicines that it wants to finance through a savings plan. The French pharmaceutical giant has decided to make Consumer Health “an autonomous global commercial entity … Read more

Sanofi could separate from its consumer health business and products like Doliprane, Mucosolvan or Novanuit

2023-10-27 07:02:24 The French pharmaceutical group Sanofi announced on Friday October 27 its intention to separate from its consumer health business in 2024 to focus on innovative medicines and vaccines. This activity includes food supplements and various products sold without a prescription such as Mucosolvan for coughs, Allegra for rhinitis and the Novanuit brand for … Read more

Livmed’s in the sights of the Order of Pharmacists

2023-10-24 20:40:41 Stupor, incomprehension. At the headquarters of Livmed’s, in Nice (Alpes-Maritimes), the emotion aroused by the attack, at the beginning of the year, of the National Council of the Order of Pharmacists is still strong. This January 10, the start-up specializing in rapid home delivery of medicines is working on the company’s next developments … Read more

Medicines against obesity, a gigantic market to conquer

2023-10-24 04:00:54 The Lilly factory in Fegersheim (Bas-Rhin), October 18, 2023. JEAN-FRANçOIS BADIAS / PHOTOPQR / DNA / MAXPPP Great pride. In the ranks of Lilly employees and management at the Fegersheim factory (Bas-Rhin), a few kilometers from Strasbourg, the arrival of Mounjaro, the future star of treatments against obesity and diabetes, has made jump … Read more

Is the pharmaceutical industry too expensive in Belgium? “A billion euros are overspent per year”

2023-10-16 07:01:00 The guest on Bel RTL’s 7:50 am this Monday was the general director of Solidaris, Jean-Pascal Labille. He answered questions from Martin Buxant, particularly on the links between health and the State. This Monday morning, the general director of Solidaris was the guest of Martin Buxant on Bel RTL matin. The socialist mutuality … Read more

Cardiovascular Safety of CONTRAVE®/MYSIMBA®: Study Results and Analysis

2023-10-18 18:45:57 Brentwood, Tennessee (ots/PRNewswire) Currax Pharmaceuticals LLC (“Currax”) today announced the initial results of a Cardiovascular Health Outcomes Analysis (HOA). This study evaluated the cardiovascular safety of CONTRAVE®/MYSIMBA®, a weight management medication. The real-world study evaluated CONTRAVE®/MYSIMBA ® compared to a similar product to measure major adverse cardiovascular events (MACE). The primary analysis included … Read more

The Impact of Ozempic’s Success on Snacking and Fast Food Brands: A Stock Market Disruption

2023-10-14 06:39:55 The success of Ozempic, a drug to treat diabetes but diverted for weight loss purposes, has caused victims on the stock market since the beginning of October. Famous snacking and fast food brands have become the target of investors who are already anticipating a disruption in consumer habits. In almost ten days, the … Read more